Invesco S&P 500 BuyWrite ETF(PBP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

PBP Invesco S&P 500 BuyWrite ETF

Closed 05-19 16:00:00 EDT

22.50

-0.10

-0.44%

盘后22.50

+0.000.00%

16:10 EDT

High22.56	Low22.45	Vol23.05K
Open22.56	D1 Closing22.60	Amplitude0.49%
Mkt Cap339.75M	Tradable Cap339.75M	Total Shares15.10M
T/O518.49K	T/O Rate0.15%	Tradable Shares15.10M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"PBP","market":"US","secType":"STK","nameCN":"Invesco S&P 500 BuyWrite ETF","latestPrice":22.5,"timestamp":1779220800000,"preClose":22.6,"halted":0,"volume":23047,"hourTrading":{"tag":"盘后","latestPrice":22.5,"preClose":22.5,"latestTime":"16:10 EDT","volume":17,"amount":382.5,"timestamp":1779221404509,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.004424778761062009,"floatShares":15100000,"shares":15100000,"eps":0,"marketStatus":"Closed","change":-0.1,"latestTime":"05-19 16:00:00 EDT","open":22.56,"high":22.56,"low":22.45,"amount":518493.260874,"amplitude":0.004867,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1779264000000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"CBOE","adjPreClose":22.6,"sharesOutstanding":14400000,"nav":22.523789999999998,"aum":340109229,"dividendRate":0.099244,"bidAskSpread":0.001906,"preHourTrading":{"tag":"盘前","latestPrice":22.6,"preClose":22.6,"latestTime":"08:47 EDT","volume":3,"amount":67.80000000000001,"timestamp":1779194825687,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":22.5,"preClose":22.5,"latestTime":"16:10 EDT","volume":17,"amount":382.5,"timestamp":1779221404509,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.518437,"impliedVol":0.2641,"impliedVolPercentile":0.6733},"requestUrl":"/m/hq/s/PBP/tweets","defaultTab":"tweets","newsList":[{"id":"2629705718","title":"Press Release: Beta Bionics Announces First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2629705718","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629705718?lang=en_us&edition=fundamental","pubTime":"2026-04-22 04:03","pubTimestamp":1776801780,"startTime":"0","endTime":"0","summary":"IRVINE, Calif., April 21, 2026  -- Beta Bionics, Inc. , a pioneering leader in the development of advanced diabetes management solutions, today reported its financial results for the quarter ended March 31, 2026 and raised its full year guidance for the year ending December 31, 2026.First Quarter 2026 Financial Highlights & Key Metrics. -- Net sales of $27.6 million, up 57% compared to $17.6 million in the first. -- Durable Medical Equipment  channel net sales of $16.9 million,up 22% compared to $13.8 million in the first quarter of 2025.-- Pharmacy Benefit Plan  channel net sales of $10.7 million, up. -- Gross margin of 59.5%, up 864 basis points compared to 50.9% in the first. -- New patient starts declined by at least 10% but less than 20%. -- High 30s percentage of new patient starts reimbursed through the. to $18.6 million or negative 106% of sales in the first quarter of 2025.million or negative 162% of sales in the first quarter of 2025.compared to negative $15.5 million or nega","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4099","BK4585","BBNX","BK4604","BK4555","BK4588","PBP","TM","03160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612460914","title":"Press Release: Beta Bionics Announces Fourth Quarter and Full Year 2025 Financial Results and Introduces Annual Guidance for Full Year 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2612460914","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612460914?lang=en_us&edition=fundamental","pubTime":"2026-02-18 05:05","pubTimestamp":1771362300,"startTime":"0","endTime":"0","summary":"IRVINE, Calif., Feb. 17, 2026  -- Beta Bionics, Inc. , a pioneering leader in the development of advanced diabetes management solutions, today reported its financial results for the quarter and year ended December 31, 2025 and introduced its annual guidance for the year ending December 31, 2026.Fourth Quarter 2025 Financial Highlights & Key Metrics. -- Net sales of $32.1 million, up 57% compared to $20.4 million in the. -- Durable Medical Equipment  channel net sales of $22.3 million,up 24% compared to $18.0 million in the fourth quarter of 2024.-- Pharmacy Benefit Plan  channel net sales of $9.8 million, up. 295% compared to $2.5 million in the fourth quarter of 2024.-- Gross margin of 59.0%, up 179 basis points compared to 57.2% in the. -- Installed customer base (calculated as all new patient starts over a. rolling four-year period) of 35,011 users, up 129% compared to 15,298 in. -- 5,592 new patient starts, up 37% compared to 4,084 new patient starts in. -- 69% of new patient start","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBNX","BK4082","PBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2602313994","title":"Beta Bionics Announces Preliminary, Unaudited Fourth Quarter 2025 Topline Financial Results and Key Metrics","url":"https://stock-news.laohu8.com/highlight/detail?id=2602313994","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602313994?lang=en_us&edition=fundamental","pubTime":"2026-01-09 05:04","pubTimestamp":1767906240,"startTime":"0","endTime":"0","summary":"IRVINE, Calif., Jan.  08, 2026  (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its preliminary,","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/08/3215777/0/en/Beta-Bionics-Announces-Preliminary-Unaudited-Fourth-Quarter-2025-Topline-Financial-Results-and-Key-Metrics.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBNX","BK4082","PBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2589358724","title":"Beta Bionics to Pre-Announce Topline Fourth Quarter 2025 Financial Results the Week of January 5, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2589358724","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589358724?lang=en_us&edition=fundamental","pubTime":"2025-12-08 20:45","pubTimestamp":1765197900,"startTime":"0","endTime":"0","summary":"IRVINE, Calif., Dec.  08, 2025  (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX) (the “Company”), a pioneering leader in the development of advanced diabetes management solutions, today announced","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/08/3201441/0/en/Beta-Bionics-to-Pre-Announce-Topline-Fourth-Quarter-2025-Financial-Results-the-Week-of-January-5-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BBNX","PBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2579997983","title":"Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2579997983","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579997983?lang=en_us&edition=fundamental","pubTime":"2025-10-29 04:02","pubTimestamp":1761681720,"startTime":"0","endTime":"0","summary":"IRVINE, Calif., Oct.  28, 2025  (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial re","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/28/3175926/0/en/Beta-Bionics-Reports-Third-Quarter-2025-Financial-Results-and-Raises-Full-Year-2025-Guidance.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBNX","BK4181","PD","BK4023","LU1169589451.USD","BK4218","BK4082","PK","LU1169590202.USD","PBP"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0079},{"period":"1month","weight":-0.0013},{"period":"3month","weight":-0.0109},{"period":"6month","weight":0.0022},{"period":"1year","weight":0.04},{"period":"ytd","weight":-0.0101}],"compareEarnings":[{"period":"1week","weight":-0.0009},{"period":"1month","weight":0.0401},{"period":"3month","weight":0.0817},{"period":"6month","weight":0.1147},{"period":"1year","weight":0.2431},{"period":"ytd","weight":0.0832}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"The fund generally will invest at least 90% of its total assets in securities that comprise the underlying index and will write (sell) call options thereon. The underlying index is a total return benchmark index that is designed to track the performance of a hypothetical \"buy-write\" strategy on the S&P 500® Index.","yearOnYearQuotes":[{"month":1,"riseRate":0.526316,"avgChangeRate":-0.005223},{"month":2,"riseRate":0.684211,"avgChangeRate":0.002119},{"month":3,"riseRate":0.684211,"avgChangeRate":0.001257},{"month":4,"riseRate":0.789474,"avgChangeRate":0.010765},{"month":5,"riseRate":0.526316,"avgChangeRate":-0.001291},{"month":6,"riseRate":0.5,"avgChangeRate":-0.005782},{"month":7,"riseRate":0.833333,"avgChangeRate":0.016942},{"month":8,"riseRate":0.5,"avgChangeRate":-0.001904},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.012491},{"month":10,"riseRate":0.555556,"avgChangeRate":0.002505},{"month":11,"riseRate":0.777778,"avgChangeRate":0.011816},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.018554}],"exchange":"CBOE","name":"Invesco S&P 500 BuyWrite ETF","nameEN":"Invesco S&P 500 BuyWrite ETF"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Invesco S&P 500 BuyWrite ETF(PBP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Invesco S&P 500 BuyWrite ETF(PBP) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Invesco S&P 500 BuyWrite ETF,PBP,Invesco S&P 500 BuyWrite ETF股票,Invesco S&P 500 BuyWrite ETF股票老虎,Invesco S&P 500 BuyWrite ETF股票老虎国际,Invesco S&P 500 BuyWrite ETF行情,Invesco S&P 500 BuyWrite ETF股票行情,Invesco S&P 500 BuyWrite ETF股价,Invesco S&P 500 BuyWrite ETF股市,Invesco S&P 500 BuyWrite ETF股票价格,Invesco S&P 500 BuyWrite ETF股票交易,Invesco S&P 500 BuyWrite ETF股票购买,Invesco S&P 500 BuyWrite ETF股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Invesco S&P 500 BuyWrite ETF(PBP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Invesco S&P 500 BuyWrite ETF(PBP) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction